Welcome
Welcome to the Investor Relations section of Vitruvia. This area is dedicated to keeping shareholders and potential investors up to date with relevant information on Vitruvia and its shares.
Press releases
January 19, 2023
New cooperation of LT technologies GmbH & Co. KG with TRES MEDICO, Malaysia
Our affiliate LT technologies has entered a cooperation in the field of repair service with the…
September 28, 2022
Successful certification of FFP 2 masks with medical approval of LT technologies
LT technologies has successfully passed the certification of the FFP2 masks with medical approval.
September 13, 2021
Vitruvia Medical AG reports first-half 2021 results in line with expectations. Board of Directors confirms full-year and 2022 forecasts
Anglikon, September 13, 2021 Vitruvia Medical AG is right on target after the first six months of…
Ad-hoc News
September 29, 2023
Consolidated inter results as per June 30th, 2023
Vitruvia Medical AG achieves results as expected in the first half of 2023. The Board of Directors…
June 26, 2023
Annual results as of 31.12.2022 and outlook 2023
Vitruvia Medical AG reported net income after taxes of CHF -1,095,349.38 for the year ended…
March 29, 2023
Vitruvia Medical AG has carried out an authorised capital increase
Vitruvia Medical AG has carried out an authorised capital increase as of today.
Key performance indicatorsVitruvia Medical AG share
Name | Werte |
---|---|
Number of shares | The share capital is CHF 2'511'578.00 and is divided into 2'511'578 registered shares, each with a nominal value of CHF 1.00 |
WKN | A2PDWF |
ISIN | CH0461931419 |
Valor | CH046193141 |
Availability of shares | All registered shares are freely transferable. |
End of fiscal year | December 31 |
Stock exchange | Munich Stock Exchange |
Market segment | General open market |
Initial listing | May 11, 2021 |
Course data
Name | Werte |
---|---|
Current share price (Link to Munich Stock Exchange) | |
52-Week-High | EUR 11,50 |
52-Week-Low | EUR 1,00 |
Dates
Nov 13, 2023 | Extraordinary General Assembly
Sep 30, 2023 | Publication of half-year financial statements as of June 30, 2023
Jul 26, 2023 | Annual general meeting Vitruvia Medical AG
Aug 02, 2022 | Annual General Assembly
Financial reports
Management Transactions
Your contact
Markus A. Bertschin
President of the Board of Directors
T +41 (0)44 915 33 78
M +41 (0)79 233 26 09
bertschin@vitruvia-med.com
Vitruvia Medical AG
Kesselackerstrasse 18
5611 Anglikon I Switzerland
Newsletter
Do you want to be informed about company news and reports on a regular basis? Then sign up for our newsletter.